A TrxR inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Aurothioglucose (hydrate)

Item No. 30732

Technical Information
Synonyms
  • Gold Thioglucose
Molecular Formula
C6H11AuO5S • XH2O
Formula Weight
Purity
≥80%
Formulation
A solid
SMILES
O[C@@H]([C@@H]1O)[C@]([OH][Au+][S-]2)([H])C2O[C@@H]1CO.O
InChi Code
InChI=1S/C6H12O5S.Au.H2O/c7-1-2-3(8)4(9)5(10)6(12)11-2;;/h2-10,12H,1H2;;1H2/q;+1;/p-1/t2-,3-,4+,5-,6?;;/m1../s1
InChi Key
SGVIEHTYEMEDRR-DUMCKRSRSA-M
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    Aurothioglucose is an inhibitor of thioredoxin reductase (TrxR; IC50 = 0.065 µM for the human placental enzyme).1 It is selective for TrxR over glutathione reductase and glutathione peroxidase (GPX; IC50s = >100 and 80 µM, respectively). Aurothioglucose (100 µM) inhibits IL-1β-induced production of IL-6 and IL-8 in isolated human rheumatoid synovial fibroblasts.2 It reduces HIV-1 replication induced by TNF-α in OM10.1 cells latently infected with HIV-1 when used at concentrations of 10 and 25 µM.3 Aurothioglucose (25 mg/kg) improves survival in a mouse model of acute respiratory distress syndrome (ARDS) induced by LPS and hyperoxia.4 It induces obesity and increases food intake and blood glucose levels in genetically diabetic KK mice.5 Formulations containing aurothioglucose have previously been used in the treatment of rheumatoid arthritis.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Gromer, S., Arscott, L.D., Williams, C.H., Jr., et alHuman placenta thioredoxin reductase. Isolation of the selenoenzyme, steady kinetics, and inhibition by therapeutic gold compounds. The Journal of Biological Chemisty 273(32), 20096-20101 (1998).

    2. Yoshida, S., Kato, T., Sakurada, S., et alInhibition of IL-6 and IL-8 induction from cultured rheumatoid synovial fibroblasts by treatment with aurothioglucose. Int. Immunol. 11(2), 151-158 (1999).

    3. Traber, K.E., Okamoto, H., Kurono, C., et alAnti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-α-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells. Int. Immunol. 11(2), 143-150 (1999).

    4. Britt, R.D., Jr., Velten, M., Locy, M.L., et alThe thioredoxin reductase-1 inhibitor aurothioglucose attenuates lung injury and improves survival in a murine model of acute respiratory distress syndrome. Antioxid. Redox Signal. 20(17), 2681-2691 (2014).

    5. Matsuo, T., and Shino, A. Induction of diabetic alterations by goldthioglucose-obesity in KK,ICR and C57BL mice. Diabetologia 8(6), 391-397 (1972).